Pharma and BioTech Daily
By Pharma and BioTech News
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Pharma and BioTech News
Category: Tech News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 6
Reviews: 0
Episodes: 53
Description
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.
Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.
Produced by OWITH.ai, a boutique AI & data studio.
Sponsor the show: https://sponsor.owith.ai
| Episode | Date |
|---|---|
|
Zealand Pharma & Generate Biomedicines' $1.2B AI Deal | Pharma and Biotech Daily
|
Oct 15, 2026 |
|
GSK Invests $800M in Biologics Facility | Pharma and Biotech Daily
|
Oct 14, 2026 |
|
Asahi Kasei's $920M AiCuris Buy Leads to FDA OK | Pharma and Biotech Daily
|
Oct 13, 2026 |
|
GSK AI Partnership & Roche's FDA Win: $117M IPO Buzz | Pharma and Biotech Daily
|
Oct 12, 2026 |
|
Novartis' Rhapsido FDA Expansion Boosts Revenue Potential | Pharma and Biotech Daily
|
Oct 09, 2026 |
|
Cerevance's Solengepras Hits Phase 3 Success for Parkinson's | Pharma and Biotech Daily
|
Oct 08, 2026 |
|
Shionogi Acquires Intrabio for $2B: Rare Disease Focus | Pharma and Biotech Daily
|
Oct 07, 2026 |
|
Bayer's $2.2B Ohio Site Boosts U.S. Pharma | Pharma and Biotech Daily
|
Oct 06, 2026 |
|
Novartis's $7.8B mRNA Deal with Abogen | Pharma and Biotech Daily
|
Oct 05, 2026 |
|
Sanofi's $1B Deal with Regeneron: Immunology Breakthroughs | Pharma and Biotech Daily
|
Oct 02, 2026 |
|
Eli Lilly's Retatrutide: 25% Weight Loss in Phase 3 Trial! | Pharma and Biotech Daily
|
Oct 01, 2026 |
|
AstraZeneca's $2B Oncology Investment | Pharma and Biotech Daily
|
Sep 30, 2026 |
|
AbbVie Juvmo FDA Approved: Parkinson's Breakthrough | Pharma and Biotech Daily
|
Sep 29, 2026 |
|
Merck's FDA Win: Welireg & Lenvima Breakthrough | Pharma and Biotech Daily
|
Sep 28, 2026 |
|
Eli Lilly's $2B Onswik FDA Approval Revolutionizes Diabetes | Pharma and Biotech Daily
|
Sep 25, 2026 |
|
AstraZeneca's Trixeo EU Approval & Boehringer's $250M Deal | Pharma and Biotech Daily
|
Sep 24, 2026 |
|
Boehringer Ingelheim's $1B AI Deal & FDA Trials Update | Pharma and Biotech Daily
|
Sep 23, 2026 |
|
Telix Buys ITM for $2.35B | Pharma and Biotech Daily
|
Sep 22, 2026 |
|
Ultragenyx’s $4M Fayuvi FDA Approval Breakthrough | Pharma and Biotech Daily
|
Sep 21, 2026 |
|
Bayer's Kerendia Secures 3rd FDA Approval | Pharma and Biotech Daily
|
Sep 18, 2026 |
|
Novartis Acquires Sironax Platform for $125M | Pharma and Biotech Daily
|
Sep 17, 2026 |
|
GSK Acquires Chimagen's Tech for $750M | Pharma and Biotech Daily
|
Sep 16, 2026 |
|
Scholar Rock's $20B Pharma Shakeup & More | Pharma and Biotech Daily
|
Sep 15, 2026 |
|
Moderna's $1B mRNA Cancer Vaccine Boosts Personalized Meds | Pharma and Biotech Daily
|
Sep 14, 2026 |
|
FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily
|
Sep 11, 2026 |
|
Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily
|
Sep 10, 2026 |
|
AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily
|
Sep 09, 2026 |
|
FDA Approves Alzheimer's Drug: Major $ Breakthrough | Pharma and Biotech Daily
|
Sep 08, 2026 |
|
Ionis' Zanvastro FDA Approved: $771M Partnership Impact | Pharma and Biotech Daily
|
Sep 07, 2026 |
|
Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily
|
Sep 04, 2026 |
|
AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily
|
Sep 03, 2026 |
|
Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily
|
Sep 02, 2026 |
|
Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily
|
Sep 01, 2026 |
|
Eli Lilly's $173M FDA Win: Mounjaro Approved! | Pharma and Biotech Daily
|
Aug 31, 2026 |
|
Revolution Medicines' $2.25B FDA Approval Milestone | Pharma and Biotech Daily
|
Aug 28, 2026 |
|
Revolution Medicines FDA Win: RAS Inhibitor Approved | Pharma and Biotech Daily
|
Aug 27, 2026 |
|
FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily
|
Aug 26, 2026 |
|
Roche & Hanmi's $2.5B Obesity Drug Deal | Pharma and Biotech Daily
|
Aug 25, 2026 |
|
Roche's $750M Genentech Expansion Boosts Biologics | Pharma and Biotech Daily
|
Aug 24, 2026 |
|
Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily
|
Aug 21, 2026 |
|
Merck's $1B Melanoma Vaccine Breakthrough | Pharma and Biotech Daily
|
Aug 20, 2026 |
|
Biokin's $275M ADC Success in Phase 3 Trial | Pharma and Biotech Daily
|
Aug 19, 2026 |
|
AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC | Pharma and Biotech Daily
|
Aug 18, 2026 |
|
FDA Fast-Tracks NASH Drug | Pharma and Biotech Daily
|
Aug 17, 2026 |
|
AstraZeneca's Baxfendy Setback: Pricing Woes | Pharma and Biotech Daily
|
Aug 14, 2026 |
|
Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily
|
Aug 13, 2026 |
|
Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs | Pharma and Biotech Daily
|
Aug 12, 2026 |
|
Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough | Pharma and Biotech Daily
|
Aug 11, 2026 |
|
Replimune's FDA Win: Tudriqev Approved After 2 Rejections | Pharma and Biotech Daily
|
Aug 10, 2026 |
|
Moderna mRNA Flu Vaccine Approved by FDA | Pharma and Biotech Daily
|
Aug 07, 2026 |
|
Eli Lilly's $23B Q2 Revenue Breaks Records | Pharma and Biotech Daily
|
Aug 06, 2026 |
|
Otsuka's Voyxact Shines in Phase 3 Trial | Pharma and Biotech Daily
|
Aug 05, 2026 |
|
Supernus & Indivior $2.2B Merger Creates CNS Giant | Pharma and Biotech Daily
|
Aug 04, 2026 |